As light travels deeper into the brain, it scatters. Three-photon microscopy, the current state of the art, reduces the resulting background fluorescence and can, in principle, image much deeper than earlier techniques—but ...
Oct 28, 2026
0
22
Commonly used injections for Achilles tendinopathy—pain, stiffness and swelling in the Achilles tendon—offer no meaningful clinical advantage over placebo (sham) treatment, finds a clinical trial published by The BMJ.
Oct 28, 2026
0
22
A team of researchers has found that a breakdown product from a commonly consumed fat can bind to a receptor associated with psoriatic itch and inflammation. By blocking the receptor, the researchers saw a reduction in psoriatic ...
Oct 29, 2026
0
22
As the season for respiratory syncytial virus (RSV) and other respiratory diseases approaches, a new report from the European Centre for Disease Prevention and Control (ECDC) indicates that universal immunization of newborns ...
Oct 28, 2026
0
21
In a study led by Baylor College of Medicine and the University of Oxford, researchers found that blocking a specific molecular interaction reduced atrial fibrosis in mouse models and cells from human patients with atrial ...
Oct 30, 2026
0
20
GLP-1 (glucagon-like peptide-1 receptor agonists) medications, currently popular for weight loss, may help prevent type 2 diabetes and lower the risk of heart attack and stroke more than the standard diabetes prevention medication ...
Nov 2, 2026
0
20
A new Simon Fraser University study suggests that brains in healthy older adults may cope better with a lack of sleep than those in younger adults.
Oct 29, 2026
0
20
Obesity touches countless lives across the country and can lead to many other health complications. From August 2021 to 2023, the prevalence of obesity in adults in the U.S. was more than 40%. Research published in Science ...
Oct 27, 2026
0
20
The reliable assessment of metabolic dysfunction-associated steatotic liver disease (MASLD) is crucial for determining the stage of the disease, initiating appropriate treatments and monitoring the course of therapy. To date, ...
Nov 1, 2026
0
20
In a global phase 1 trial, trastuzumab rezetecan showed promising signs of fighting ERBB2-low metastatic breast cancer in patients who had already undergone extensive treatment. Also known as HER2-low breast cancer, this ...
